Iciar Pascual Miguel

Dr. Iciar Pascual Miguel

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 March 2017 in Microsurgery
Verified
Journal Article
Closed access
PDF file
CLCristian carrasco lopez
Cristian carrasco lopez
JJJoan Francesc Julián
Joan Francesc Julián
JVJordi Vilà
Jordi Vilà
MTMiguel Angel Luna Tomás
Miguel Angel Luna Tomás
JLJordi Navinés López
Jordi Navinés López
CHCarmen Higueras‐Suñe
Carmen Higueras‐Suñe

1 March 2021 in Surgical Oncology
Verified
Journal Article
Closed access
AMAntonio Mariscal Martínez
Antonio Mariscal Martínez
IRIrene Vives Roselló
Irene Vives Roselló
AGAngela Salazar Gómez
Angela Salazar Gómez
ACAlessandro Catanese
Alessandro Catanese
MMMariola Pérez Molina
Mariola Pérez Molina
MTMiguel Angel Luna Tomás
Miguel Angel Luna Tomás

1 January 2017 in Chirurgia
Verified
Journal Article
Closed access
MPMihai Paduraru
Mihai Paduraru
LPLuca Ponchietti
Luca Ponchietti
ICIsidro Martinez Casas
Isidro Martinez Casas
PSPeter Svenningsen
Peter Svenningsen
JPJorge Pereira
Jorge Pereira
BUBakarne Ugarte-Sierra
Bakarne Ugarte-Sierra
Background: Geriatric surgery is rising and projected to continue at a greater rate. There is already concern about the poor outcomes for the emergency surgery in elderly. How to manage the available resources to improve outcomes in this group of patients is an important object of debate. We aimed to determine the feasibility and safety of applying ERAS pathways to emergency elderly surgical patients. Two searches were undertaken for ERAS protocols in elderly patients and emergency surgery, in order to gather evidence in relation to ERAS in geriatric emergency patients. Primary outcomes were postoperative complications, mortality, hospital length of stay and readmission rates. Results: Eighteen studies were included. The majority of patients were older than 70. Elderly patients had fewer postoperative complications and a reduced hospitalization with ERAS compared to conventional care. Emergency surgical patients also had fewer postoperative complications with ERAS compared to conventional care. Hospital stay was reduced in 2 out of 3 studies for emergency surgery. Conclusions: ERAS can be safely applied to elderly and emergency patients with a reduction in postoperative complications, hospitalization and readmission rates. There is evidence to suggest that ERAS is feasible and beneficial for geriatric emergency patients.

27 September 2017 in International Journal of Cancer
Verified
Journal Article
Open access
PDF file
Aram BoadaAram Boada
Aram Boada
ATAntonio Tejera-Vaquerizo
Antonio Tejera-Vaquerizo
SRSimone Ribero
Simone Ribero
SPSusana Puig
Susana Puig
DMDavid Moreno-Ramírez
David Moreno-Ramírez
Eduardo NagoreEduardo Nagore
Eduardo Nagore
The clinical value of sentinel lymph node (SLN) biopsy in thick melanoma patients (Breslow >4 mm) has not been sufficiently studied. The aim of the study is to evaluate whether SLN biopsy increases survival in patients with thick cutaneous melanoma, and, as a secondary objective, to investigate correlations between survival and lymph node status. We included 1,211 consecutive patients with thick melanomas (>4 mm) registered in the participating hospitals' melanoma databases between 1997 and 2015. Median follow‐up was 40 months. Of these patients, 752 were matched into pairs by propensity scores based on sex, age, tumor location, histologic features of melanoma, year of diagnosis, hospital and adjuvant interferon therapy. The SLN biopsy vs. observation was associated with better DFS [adjusted hazard ratio (AHR), 0.74; 95% confidence interval (CI) 0.61–0.90); p = 0.002] and OS (AHR, 0.75; 95% CI, 0.60–0.94; p = 0.013) but not MSS (AHR, 0.84; 95% CI, 0.65–1.08; p = 0.165). SLN‐negative patients had better 5‐ and 10‐year MSS compared with SLN‐positive patients (65.4 vs. 51.9% and 48.3 vs. 38.8%; p = 0.01, respectively). As a conclusion, SLN biopsy was associated with better DFS but not MSS in thick melanoma patients after adjustment for classic prognostic factors. SLN biopsy is useful for stratifying these patients into different prognostic groups.

3 January 2014 in Journal of Medical Case Reports
Verified
Journal Article
Open access
PDF file
BCBeatriz Oncology Cirauqui
Beatriz Oncology Cirauqui
VGVanesa Quiroga García
Vanesa Quiroga García
CRClara Lezcano Rubio
Clara Lezcano Rubio
IMIciar Pascual Miguel
Iciar Pascual Miguel
LRLaia Capdevila Riera
Laia Capdevila Riera
MMMireia Margeli
Mireia Margeli
Taxanes have demonstrated effectiveness in the treatment of breast cancer, the most common type of cancer in women. The toxicity profile of taxanes (including skin toxicities) induces dose adjustment, delay, or discontinuation, which prevents a sufficient dose intensity to achieve a response. Nanoparticle albumin-bound paclitaxel, a solvent-free form of paclitaxel, prevents toxicities and reduces the pharmacokinetic interferences between paclitaxel and other drugs.

12 October 2024 in Cells
Verified
Journal Article
Open access
PDF file
DHDaniel Humaran
Daniel Humaran
JPJaviera Perez-Anker
Javiera Perez-Anker
PFPedro Luis Fernández
Pedro Luis Fernández
LBLidia Blay
Lidia Blay
IMIciar Pascual Miguel
Iciar Pascual Miguel
JJJoan Francesc Julián
Joan Francesc Julián
Ex vivo fusion confocal microscopy (EVFCM) enables the rapid examination of breast tissue and has the potential to reduce the surgical margins and the necessity for further surgeries. Traditional methods, such as frozen section analysis, are limited by the distortion of tissue and artefacts, leading to false negatives and the need for additional surgeries. This study on observational diagnostic accuracy evaluated the ability of EVFCM to detect breast cancer. A total of 36 breast tissue samples, comprising 20 non-neoplastic and 16 neoplastic cases, were analysed using EVFCM and compared to the results obtained from routine histopathology. A Mohs surgeon experienced in EVFCM (evaluator A) and two breast pathologists unfamiliar with EVFCM (evaluators B and C) performed blinded analyses. EVFCM showed high concordance with the histopathology and the detection of neoplasia, with significant kappa values (p < 0.001). Evaluator A achieved 100% sensitivity and specificity. Evaluators B and C achieved a sensitivity of >87%, a specificity of >94%, positive predictive values of >95%, and negative predictive values of 81% and 94%, respectively. EVFCM therefore offers a promising technique for the assessment of margins in breast-conserving surgery. Its widespread adoption could significantly reduce re-excisions, lower healthcare costs, and improve cosmetic and oncological outcomes.